Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jonathan H Davis"'
Autor:
Jennifer Cable, Erica Ollmann Saphire, Adrian C. Hayday, Timothy D. Wiltshire, Jarrod J. Mousa, David P. Humphreys, Esther C. W. Breij, Pierre Bruhns, Matteo Broketa, Genta Furuya, Blake M. Hauser, Matthieu Mahévas, Andrea Carfi, Tineke Cantaert, Peter D. Kwong, Prabhanshu Tripathi, Jonathan H. Davis, Neil Brewis, Bruce A. Keyt, Felix L. Fennemann, Vincent Dussupt, Arvind Sivasubramanian, Philip M. Kim, Reda Rawi, Eve Richardson, Daniel Leventhal, Rachael M. Wolters, Cecile A. W. Geuijen, Matthew A. Sleeman, Niccolo Pengo, Francesca Rose Donnellan
Publikováno v:
Annals of the New York Academy of Sciences. 1519:153-166
Therapeutic antibodies have broad indications across diverse disease states, such as oncology, autoimmune diseases, and infectious diseases. New research continues to identify antibodies with therapeutic potential as well as methods to improve upon e
Autor:
Feng Wang, Jordan C. Tsai, Jonathan H. Davis, Bryant Chau, Jia Dong, Sean M. West, Jason M. Hogan, Matthew L. Wheeler, Christine Bee, Winse Morishige, Thomas Cayton, Donata David-brown, Chengyue Zhang, Alexander Kozhich, Tim Sproul, Gavin Dollinger, Arvind Rajpal, Pavel Strop
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
The development of antibody therapeutics relies on animal models that accurately recapitulate disease biology. Syngeneic mouse models are increasingly used with new molecules to capture the biology of complex cancers and disease states, and to provid
Externí odkaz:
https://doaj.org/article/f8bc83b729b6455e90c4ca6aa57051c9
Publikováno v:
Heart (British Cardiac Society). 107(16)
Co-occurring substance use disorders (SUDs) and heart failure (HF) create a perfect storm: the drug drives cardiac pathophysiology, while complex psychosocial factors interfere with treatment efforts. Patients with SUDs and HF are less likely to enga
Autor:
Lucas S. Zier, Alexandra B Steverson, Rachel J. Stern, Caren Chen, Paul J Marano, Yifei Ma, Priscilla Y. Hsue, Jonathan H. Davis
Publikováno v:
Circulation. 142
Introduction: Safety net hospitals are more likely to be penalized for heart failure (HF) readmissions. There is limited evidence as to whether readmission reduction strategies are effective in this setting. We hypothesized that a discharge checklist
Autor:
Pavel Strop, Feng Wang, Donata David-brown, Bryant Chau, Christine Bee, Jordan C Tsai, Alexander T. Kozhich, Arvind Rajpal, Jason M. Hogan, Sean M. West, Thomas Cayton, Jia Dong, Tim Sproul, Winse Morishige, Matthew L. Wheeler, Jonathan H Davis, Chengyue Zhang, Gavin Dollinger
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The development of antibody therapeutics relies on animal models that accurately recapitulate disease biology. Syngeneic mouse models are increasingly used with new molecules to capture the biology of complex cancers and disease states, and to provid
Autor:
Thomas McDonagh, David L. Wensel, Sebastien Tabruyn, Zhufang Li, Tracy S. Mitchell, Jonathan H. Davis, Yongnian Sun, Sharon Zhang, Mark Krystal, Mark I. Cockett, Patrick Nef, David R. Langley
Long-acting antiretrovirals could provide a useful alternative to daily oral therapy for HIV-1-infected individuals. Building on a bi-specific molecule with adnectins targeting CD4 and gp41, a potential long-acting biologic, GSK3732394, was developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c17986092965a8eab3c5db82a28136fd
https://europepmc.org/articles/PMC6798092/
https://europepmc.org/articles/PMC6798092/
Autor:
Jonathan H. Davis, Jill M. Gelow, James O. Mudd, Howard K. Song, Castigliano M. Bhamidipati, Ashley E. Morgan, Frederick A. Tibayan, Elizabeth N. Dewey
Publikováno v:
American journal of surgery. 218(4)
Background Aging and loss of estrogen suppress immune function, potentially improving survival after orthotopic heart transplant (OHT). The effect of female aging on OHT outcomes is unknown. Methods Between 1995 and 2015, 41,299 adult OHT recipients
Autor:
Jonas Enander, Jose Beltrán Jiménez, Philip Bull, Seshadri Nadathur, Bin Hu, Eloisa Bentivegna, Emilio Bellini, Edvard Mörtsell, Ignacy Sawicki, Signe Riemer-Sørensen, Sebastien Clesse, Ippocratis D. Saltas, Massimiliano Rinaldi, Adam R. Solomon, Julian Adamek, L. Verde, Daniele A. Steer, Francisco Villaescusa-Navarro, Ismael Tereno, Enea Di Dio, Hans A. Winther, Marcel S. Pawlowski, Thiago S. Pereira, Glenn D. Starkman, Tessa Baker, Johannes Noller, Lavinia Heisenberg, Miguel Quartin, Douglas Spolyar, Roman Pasechnik, Yashar Akrami, Jonathan H. Davis, Vincenzo Salzano, Mikael von Strauss, Alan Heavens, Jeremy Sakstein, Stefano Camera, A. Ricciardone, Claudio Llinares, Roy Maartens
Publikováno v:
Bull, P, Akrami, Y, Adamek, J, Baker, T, Bellini, E, Jiménez, J B, Bentivegna, E, Camera, S, Clesse, S, Davis, J H, Dio, E D, Enander, J, Heavens, A, Heisenberg, L, Hu, B, Llinares, C, Maartens, R, Mörtsell, E, Nadathur, S, Noller, J, Pasechnik, R, Pawlowski, M S, Pereira, T S, Quartin, M, Ricciardone, A, Riemer-Sørensen, S, Rinaldi, M, Sakstein, J, Saltas, I D, Salzano, V, Sawicki, I, Solomon, A R, Spolyar, D, Starkman, G D, Steer, D, Tereno, I, Verde, L, Villaescusa-Navarro, F, Strauss, M V & Winther, H A 2016, ' Beyond ΛCDM : problems, solutions, and the road ahead ', Physics of the Dark Universe, vol. 12, pp. 56-99 . https://doi.org/10.1016/j.dark.2016.02.001
Physics of the Dark Universe
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Bull, P, Akrami, Y, Adamek, J, Baker, T, Bellini, E, Beltrán Jiménez, J, Bentivegna, E, Camera, S, Clesse, S, Davis, J H, Di Dio, E, Enander, J, Heavens, A, Heisenberg, L, Hu, B, Llinares, C, Maartens, R, Mörtsell, E, Nadathur, S, Noller, J, Pasechnik, R, Pawlowski, M S, Pereira, T S, Quartin, M, Ricciardone, A, Riemer-Sørensen, S, Rinaldi, M, Sakstein, J, Saltas, I D, Salzano, V, Sawicki, I, Solomon, A R, Spolyar, D, Starkman, G D, Steer, D, Tereno, I, Verde, L, Villaescusa-Navarro, F, von Strauss, M & Winther, H A 2016, ' Beyond ΛCDM : Problems, solutions, and the road ahead ', Physics of the Dark Universe, vol. 12, pp. 56-99 . https://doi.org/10.1016/j.dark.2016.02.001
Physics of the Dark Universe
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Bull, P, Akrami, Y, Adamek, J, Baker, T, Bellini, E, Beltrán Jiménez, J, Bentivegna, E, Camera, S, Clesse, S, Davis, J H, Di Dio, E, Enander, J, Heavens, A, Heisenberg, L, Hu, B, Llinares, C, Maartens, R, Mörtsell, E, Nadathur, S, Noller, J, Pasechnik, R, Pawlowski, M S, Pereira, T S, Quartin, M, Ricciardone, A, Riemer-Sørensen, S, Rinaldi, M, Sakstein, J, Saltas, I D, Salzano, V, Sawicki, I, Solomon, A R, Spolyar, D, Starkman, G D, Steer, D, Tereno, I, Verde, L, Villaescusa-Navarro, F, von Strauss, M & Winther, H A 2016, ' Beyond ΛCDM : Problems, solutions, and the road ahead ', Physics of the Dark Universe, vol. 12, pp. 56-99 . https://doi.org/10.1016/j.dark.2016.02.001
Despite its continued observational successes, there is a persistent (and growing) interest in extending cosmology beyond the standard model, ΛCDM. This is motivated by a range of apparently serious theoretical issues, involving such questions as th
Autor:
Litao Zhang, William J. Metzler, Shana L. Posy, Robert M. Borzilleri, Yuval Blat, Brigitte Devaux, Charu Chaudhry, Randy Talbott, Chunhong Yan, Yong Zhang, Jonathan H. Davis, Ming Lei, Henry Shen
Publikováno v:
Analytical Biochemistry. 497:8-17
XIAP (X-chromosome-linked inhibitor of apoptosis protein) is a central apoptosis regulator that blocks cell death by inhibiting caspase-3, caspase-7, and caspase-9 via binding interactions with the XIAP BIR2 and BIR3 domains (where BIR is baculovirus
Autor:
Jonathan H. Davis, Alejandro Moro, Aaron P. Yamniuk, Martine Loubeau, Yuguang Ban, Thomas R. Malek, Aixin Yu, Jaren M. Arbanas, Anil Thankappan, Sunnie Hsiung, Xi Chen, James Keegan, Mary Struthers, Natasha C. Ward
Low-dose IL-2 represents an immunotherapy to selectively expand regulatory T cells (Tregs) to promote tolerance in patients with autoimmunity. In this article, we show that a fusion protein (FP) of mouse IL-2 and mouse IL-2Rα (CD25), joined by a non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb78e3d1a456ad2bd65ff1f98b1779bb
https://europepmc.org/articles/PMC6200646/
https://europepmc.org/articles/PMC6200646/